Sign inJoin waitlistJoin the waitlist

PJ

Prasun Jalal

Stan and Sue Partee Endowed Chair in Hepatology · Baylor College of Medicine

Credentials: · · · ·

History

Baylor College of Medicine
Present

Transplant Hepatology
Mount Sinai School Of Medicine
2000–2001
Gastroenterology
Long Island Jewish Medical Center-Albert Einstein College of Medicine
1997–2000
Internal Medicine
1994–1997
Postgraduate Institute of Medical Education and Research, Chandigarh, India
1990–1994

Research

Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma
Gastroenterology · 2019 · 171 citations
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
Gastroenterology · 2019 · 140 citations
Primary small-bowel malignancy in the UK and its association with coeliac disease
QJM · 2003 · 134 citations

Amit Singal
12 papers
Neehar Parikh
12 papers
Ahmed Kaseb
11 papers
Fasiha Kanwal
11 papers
John Goss
11 papers
Doug Simonetto
10 papers · 1 as a fellow
Ashwani Singal
9 papers
Asif Rashid
9 papers
Antone Opekun
8 papers
AM
Ayse Mindikoglu
8 papers
Patrick Kamath
8 papers
RA
Ramon Bataller Alberola
8 papers

Grants

Toward Translation of Nanophotonic Single Exosome Liquid Biopsy for Hepatocellular Carcinoma Screening and Diagnosis
National Cancer Institute · R01
PI · $656.9K · University of Houston
2026–2030
Crosstalk Between Gut Microbiota and Hepatocellular Carcinoma Induced by Metabolic Dysfunction-Associated Steatotic Liver Disease
National Cancer Institute · R21
Contact PI · $426.4K · Baylor College of Medicine
2024–2026
Evaluation of Oral Administration of PRIM-DJ2727 Capsule Containing Microbiota Suspension in Patients with Severe Alcoholic Hepatitis: An Open-Label Study
National Institute on Alcohol Abuse and Alcoholism · R21
Contact PI · $420K · Baylor College of Medicine
2022–2024

Clinical trials

High Dose Albumin in Refractory Ascites
Principal investigator · Recruiting · Phase 2
Baylor College of Medicine
2019–2027
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Site PI · Recruiting · Phase 2
GlaxoSmithKline
2025–2028